Butyrylcholinesterase Antikörper

Produktnummer ABIN2718539

Produktdetails anti-Butyrylcholinesterase Antikörper

Target: Butyrylcholinesterase (BCHE)

Reaktivität: Human, Hund

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Butyrylcholinesterase Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Flow Cytometry (FACS)

Produktmerkmale: Homo sapiens butyrylcholinesterase (BCHE)

Aufreinigung: Purified from mouse ascites fluids by affinity chromatography

Immunogen: Full length human recombinant protein of human BCHE (NP_000046) produced in HEK293T cell.

Klon: 1E1

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: WB 1:500~2000, FLOW 1:100,

Kommentare:

The concentration of the product may vary between diferrent lots.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5-1.0 mg/mL

Buffer: PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Details zu Butyrylcholinesterase

Target: Butyrylcholinesterase (BCHE)

Andere Bezeichnung: BCHE (BCHE Produkte)

Hintergrund: Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.

Molekulargewicht: 68.2 kDa

Gen-ID: 590

NCBI Accession: NM_000055

HGNC: 590

Pathways: Peptide Hormone Metabolism